Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiangen Wu

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Trends in Endocrinology and Metabolism: TEM|July 22, 2025
Metabolic-immune microenvironment crosstalk mediating ICI resistance in MASH-HCCYi Ju, Kequan Xu, Xi Chen, et al.
Trends in Molecular Medicine|July 24, 2023
Alternative splicing: a bridge connecting NAFLD and HCCKequan Xu, Tiangen Wu, Peng Xia, et al.
Molecular Therapy Oncolytics|December 2, 2021
Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinomaTiangen Wu, Yang Ke, Haoran Tang, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 5, 2024
OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitinationLiqun Peng, Tiangen Wu, Yingyi Liu, et al.
Journal of Oncology|September 8, 2022
Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine DevelopmentWeiran Liao, Zhitian Shi, Haoren Tang, et al.
Immunotargets and Therapy|February 14, 2024
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective StudyLi Chen, Qiang Liu, Chunlei Tan, et al.
ILAR Journal|July 2, 2004
The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitusRebecca S Tirabassi, Joan F Flanagan, Tiangen Wu, et al.
Heliyon|November 29, 2023
Assessment of the albumin-bilirubin score in breast cancer patients with liver metastasis after surgeryLi Chen, Chunlei Tan, Qingwen Li, et al.
Computers in Biology and Medicine|January 10, 2024
Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinomaKequan Xu, Caixia Dai, Jialing Yang, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 31, 2020
Reduced glutathione ameliorates liver function, oxidative stress and inflammation after interventional therapy for hepatocellular carcinomaYang Ke, Tiangen Wu, Xuefen Lei, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Trends in Endocrinology and Metabolism: TEM|July 22, 2025
Metabolic-immune microenvironment crosstalk mediating ICI resistance in MASH-HCCYi Ju, Kequan Xu, Xi Chen, et al.
Trends in Molecular Medicine|July 24, 2023
Alternative splicing: a bridge connecting NAFLD and HCCKequan Xu, Tiangen Wu, Peng Xia, et al.
Molecular Therapy Oncolytics|December 2, 2021
Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinomaTiangen Wu, Yang Ke, Haoran Tang, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 5, 2024
OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitinationLiqun Peng, Tiangen Wu, Yingyi Liu, et al.
Journal of Oncology|September 8, 2022
Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine DevelopmentWeiran Liao, Zhitian Shi, Haoren Tang, et al.
Immunotargets and Therapy|February 14, 2024
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective StudyLi Chen, Qiang Liu, Chunlei Tan, et al.
ILAR Journal|July 2, 2004
The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitusRebecca S Tirabassi, Joan F Flanagan, Tiangen Wu, et al.
Heliyon|November 29, 2023
Assessment of the albumin-bilirubin score in breast cancer patients with liver metastasis after surgeryLi Chen, Chunlei Tan, Qingwen Li, et al.
Computers in Biology and Medicine|January 10, 2024
Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinomaKequan Xu, Caixia Dai, Jialing Yang, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 31, 2020
Reduced glutathione ameliorates liver function, oxidative stress and inflammation after interventional therapy for hepatocellular carcinomaYang Ke, Tiangen Wu, Xuefen Lei, et al.
Pageof 3